Drug use and addiction are less prevalent in developing countries than in wealthy countries, but illegal drug use is increasing in developing countries such as Africa, South America, the Middle East and Southeast Asia. Pharmaceutical manufacturing is traditionally associated with developing countries, but major consumers buy these substances in wealthy countries. However, recent trends show that an increasing number of people are using drugs to combat economic and social inequality in underprivileged countries. And since these countries do not have the infrastructure, public health, and treatment support that developed countries have, the consequences of an increase in the number of addicts are an unmanageable burden in countries that already have few resources. According to UNODC, or the office on Drugs and Crime, the use of synthetic drugs such as ecstasy and methamphetamine is increasing, while traditional narcotics such as heroin, cocaine, and morphine are steadily or decreasing domestically. This can have serious implications for the future of these countries, as traditional street drugs often bring significant income to underprivileged countries. Synthetic drugs can help people who are addicted by squeezing resources that are already scarce. This is annoying, given that synthetic drugs alone are worth more than US $ 65 billion worldwide. Very few enter the public health and welfare system.

Journal of Pharmacovigilance is an Open Access and Peer Reviewd Journal, aims to publish trending topics like medication error, pharmacology, Drug abuse ect,.

Submit manuscript at www.walshmedicalmedia.com/submissions/pharmacovigilance.html or send as an e-mail attachment to the Editorial Office at drugsafety@journaloa.org